Literature DB >> 6237254

The ternary complex model. Its properties and application to ligand interactions with the D2-dopamine receptor of the anterior pituitary gland.

K A Wreggett, A De Léan.   

Abstract

Agonists and antagonists interact with the pituitary D2-dopamine receptor in a complex fashion that has been accounted for by proposing that the receptor exists in two interconvertible affinity states [De Lean et al., Mol. Pharmacol. 22:290-297 (1982)]. These two states appear to be modulated by guanine nucleotides such that the state existing in the presence of excess guanine nucleotide has low affinity for agonists and high affinity for antagonists. These observations, together with several lines of evidence from other laboratories, have suggested the interaction of the receptor with a guanine nucleotide-binding protein and a model describing the reversible interaction of the receptor (R) with an additional membrane component (X) was studied [De Lean et al., J. Biol. Chem. 255:7108-7117 (1980)]. Several properties of this ternary complex model are presented and discussed in terms of the interpretation of the analysis of simulated binding data using the mass-action model. Computer modeling of experimental binding data obtained from membrane homogenates of bovine anterior pituitary glands indicated that a ternary complex model will fit only under conditions where, in the absence of any ligand, there is a tight interaction or "precoupling" of R with X, with the latter being in stoichiometrically limiting amounts; antagonists and guanine nucleotides would tend to destabilize this interaction, whereas agonists would serve to stabilize the coupled form. These results, for a receptor system that inhibits adenylate cyclase activity, are notably different from those observed for the beta-adrenergic receptor, which stimulates the enzyme and may be a reflection of differences in the molecular mechanisms of the interaction of the two receptor systems with their ligands and their effector. Some features of the model are not compatible with the experimental data and have indicated the need to consider extensions of the model, in light of recent advancements in our understanding of these regulatory components. Our results stress the importance of verifying the properties of proposed models and of cautiously testing these proposed models by their direct application to experimental data.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237254

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  35 in total

Review 1.  Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery.

Authors:  R A de Ligt; A P Kourounakis; A P IJzerman
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 2.  Oligomerization of G protein-coupled receptors: past, present, and future.

Authors:  Paul S-H Park; Slawomir Filipek; James W Wells; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2004-12-21       Impact factor: 3.162

3.  Coupling of D2 dopamine receptors to G-proteins in solubilized preparations of bovine caudate nucleus.

Authors:  J A Chazot; P G Strange
Journal:  Biochem J       Date:  1992-01-15       Impact factor: 3.857

4.  Ligands raise the constraint that limits constitutive activation in G protein-coupled opioid receptors.

Authors:  Vanessa Vezzi; H Ongun Onaran; Paola Molinari; Remo Guerrini; Gianfranco Balboni; Girolamo Calò; Tommaso Costa
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

5.  Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists.

Authors:  R Nonno; M Pannacci; V Lucini; D Angeloni; F Fraschini; B M Stankov
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

6.  Viral RNAi suppressor reversibly binds siRNA to outcompete Dicer and RISC via multiple turnover.

Authors:  Renata A Rawlings; Vishalakshi Krishnan; Nils G Walter
Journal:  J Mol Biol       Date:  2011-02-24       Impact factor: 5.469

7.  Analytical determination of receptor-ligand dissociation constants of two populations of receptors from displacement curves.

Authors:  H Almagor; A Levitzki
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

8.  Experimental design and estimation of parameters in complex radioligand binding systems.

Authors:  C M Staschen; L D Homer
Journal:  J Pharmacokinet Biopharm       Date:  1996-12

9.  Regulation of the avidity of ternary complexes containing the human 5-HT(1A) receptor by mutation of a receptor contact site on the interacting G protein alpha subunit.

Authors:  Philip J Welsby; I Craig Carr; Graeme Wilkinson; Graeme Milligan
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

10.  Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of beta 2-microglobulin.

Authors:  L F Boyd; S Kozlowski; D H Margulies
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.